|
Volumn 84, Issue 3, 1997, Pages 147-152
|
The adjuvant treatment of malignant melanoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT ALPHA2B INTERFERON;
ADJUVANT CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG COST;
DRUG EFFICACY;
FEVER;
HUMAN;
MELANOMA;
MYALGIA;
NAUSEA;
SHORT SURVEY;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
COLONIC NEOPLASMS;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
INTERFERON ALFA-2B;
LYMPH NODES;
LYMPHATIC METASTASIS;
MALE;
MELANOMA;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
RISK FACTORS;
SKIN NEOPLASMS;
SURVIVAL RATE;
|
EID: 0030926184
PISSN: 00154148
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (6)
|
References (14)
|